3D Printed Drugs Market

3D Printed Drugs Market

3D Printed Drugs Market, By Technique Type (Fused Deposition Modelling, Inkjet Printing and Others), and Geography – Global Opportunities & Forecast 20202027

GMI Research

GMI Research See the Future Insights 1

The market research offers historical and forecasts market data, demand, segmentation, price trends, and company shares of the leading players. The report splits the market size, by volume and value, on the basis of technology type and geography. First, this report covers the present status and the future prospects of the market over the forecast period. And in this report, we analyze the global market from 4 geographies: Asia-Pacific, Europe, North America, and Rest of the World. At the same time, we have classified the 3D Printed Drugs Market according to the technology type, and by regions.

For Additional Insights, Click to Access Complete Report: https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-techniquetype/ Competitive Landscape: The 3D Printed Drugs Market report also scans the competitive landscape and profiles the major players operating in the market, including Aprecia Pharmaceuticals, FabRx Ltd, GlaxoSmithKline Plc., 3D Printer Drug Machine, Hewlett Packard Caribe, BV, University of Glasgow, National University of Singapore, UCL School of Pharmacy, University College of London, and The University of Nottingham.

3D Printed Drugs Market drivers: Technological innovations in 3D printing procedures, user-friendly, and easy availability feature of the 3d printed drugs are certain factors contributing to the growth of the 3D printed drugs market. Furthermore, the ability to print drugs on-demand could decrease cost, reduce the risk of counterfeiting, increase the choice available to clinicians, and help personalize drug delivery to the requirements of individual patients is further propelling the market growth. On the other hand, antagonistic effects related to the use of these drugs, lack of government regulations linked to these drugs, and usage of 3D printing to develop illegal drugs are the major factors that are hindering the market growth. The launch of 3D printed drugs by various market players in developing countries and the increase in health care investment in emerging

2

economies are expected to create various growth opportunities in the market in the upcoming years.

Growth in prevalence of dysphagia, increased usage of 3D printing techniques in the medical & healthcare industries, rise in adoption of personalized drugs, and production of combination medicine are propelling the market growth. The 3D printed drug market could also make children far less resistant to taking their needed medication since they may be able to choose the color, design, shape, and even taste of the tablet.

These factors are further accelerating the growth of the 3D printed drug market.

The study objectives of this report are: 1. To analyze the global region’s market potential and advantages, opportunity and challenge, restraints and risks.

2. To identify significant trends and factors driving or inhibiting market growth.

3. To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

3D Printed Drugs Market Segmentation:

By Technology Type: • Fused Deposition Modelling • Inkjet Printing • Others

By Region: • North America o United States of America o Canada • Asia Pacific o China o Japan o India o Rest of APAC • Europe 3

o o o o o • RoW o o o o o

United Kingdom Germany France Spain Rest of Europe Brazil South Africa Saudi Arabia UAE Rest of the world (remaining countries of the LAMEA region)

About GMI Research GMI Research is a full-service market research and business-consulting organization that offers global as well as medium and small businesses with bespoke industry and market analysis to help them in making the toughest business decision. We have a team of industry experts that provides unbiased insights on reports to best meet the specific needs of our clients. GMI Research’s analysts rely on secondary research to lay down the foundation of every report. We use not only the internal but also the external databases to cull out relevant information of the industry. Our main aim is to keep our clients abridged of the emerging opportunities and challenges in a wide range of industries. We provide step-by-step assistance to our client, through strategic and consulting services to reach a managerial and actionable decision. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research are always looking forward to helping businesses stay ahead of the curve.

Contact Us Company Name: GMI RESEARCH Email: enquiry@gmiresearch.com Phone: +353 1 442 8820 Address: Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate 4

City: Dublin State: Dublin Country: Ireland Website: https://www.gmiresearch.com/

5